The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
247 - Could we use global data to support a worldwide market share claim which would include Canada? or is this something that can be confirmed by the sponsor's Med/Reg Department e.g. Drug X: Over 1.5 million patients worldwide.
-
Non-comparative experience claims relating to # of patients (or patient years) can be supported by either providing worldwide/Canadian data or by providing a letter from the sponsor's med/reg department confirming the claim. However, market share claims (such as #1 dispensed...) require independent data (e.g. from IQVIA, Rogers etc.) which meet the market share guidelines which can be found on the PAAB website.
